Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Step 4: Maintain consistency
Saxenda, also an incretin mimetic, was approved for obesity with the active ingredient liraglutide (and previously approved for type 2 diabetes under the name Victoza) as a daily injection
An extreme nocturnal delirious event occurred requiring physical restraint (88), and the patient expired during sleep within a few days
list-price revenue growth faces structural constraints
US$ 28.10
US$ 27.31
US$ 27.46
US$ 22.22
US$ 27.57
US$ 26.09
US$ 28.15
US$ 21.07
US$ 23.95
US$ 29.57
US$ 22.26
US$ 22.28
US$ 21.22
US$ 28.73
US$ 24.98
US$ 29.76
US$ 28.01
